Next Science | NXS - Srodki Pieniężne I Ekwiwalent



Srodki Pieniężne I Ekwiwalent Zmiana Data
Alcidion AUD 11.8M 2.84M 2024-06
Ansell USD 238.3M 674M 2025-06
Fisher & Paykel Healthcare NZD 89.9M 13.3M 2022-06
Mayne Pharma AUD 110.07M 838K 2024-06
Nanosonics AUD 161.29M 156.45M 2025-06
Polynovo AUD 29.21M 16.7M 2025-12
ResMed USD 1.42B 33.22M 2025-12